Cancer Letters
Volume 319, Issue 1 , Pages 66-82 , 1 June 2012

Combined treatment of L1CAM antibodies and cytostatic drugs improve the therapeutic response of pancreatic and ovarian carcinoma

  • Heiner Schäfer

      Affiliations

    • Department of Internal Medicine I, Laboratory of Molecular Gastroenterology & Hepatology, UKSH-Campus Kiel, Kiel, Germany
  • ,
  • Chantal Dieckmann

      Affiliations

    • Department of Internal Medicine I, Laboratory of Molecular Gastroenterology & Hepatology, UKSH-Campus Kiel, Kiel, Germany
  • ,
  • Olena Korniienko

      Affiliations

    • Institute for Experimental Cancer Research, UKSH-Campus Kiel, Kiel, Germany
  • ,
  • Gerhard Moldenhauer

      Affiliations

    • German Cancer Research Center, Translational Immunology Unit (D015), Heidelberg, Germany
  • ,
  • Helena Kiefel

      Affiliations

    • German Cancer Research Center, Translational Immunology Unit (D015), Heidelberg, Germany
  • ,
  • Alexey Salnikov

      Affiliations

    • German Cancer Research Center, Translational Immunology Unit (D015), Heidelberg, Germany
  • ,
  • Achim Krüger

      Affiliations

    • Technical University of Munich, Institute of Experimental Oncology and Therapy Research, Munich, Germany
  • ,
  • Peter Altevogt

      Affiliations

    • German Cancer Research Center, Translational Immunology Unit (D015), Heidelberg, Germany
  • ,
  • Susanne Sebens

      Affiliations

    • Department of Internal Medicine I, Laboratory of Molecular Gastroenterology & Hepatology, UKSH-Campus Kiel, Kiel, Germany
    • Institute for Experimental Medicine, UKSH-Campus Kiel, Kiel, Germany
    • Corresponding Author InformationCorresponding author at: Institute for Experimental Medicine, c/o Department of Internal Medicine I, UKHS-Campus Kiel, Arnold-Heller-Str. 3, Building 6, 24105 Kiel, Germany. Tel.: +49 431 597 3835; fax: +49 431 597 1427.

Received 26 August 2011 ,Revised 14 December 2011 ,Accepted 20 December 2011.

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.

PII: S0304-3835(11)00794-4

doi: 10.1016/j.canlet.2011.12.035

Cancer Letters
Volume 319, Issue 1 , Pages 66-82 , 1 June 2012